Abstract
Fisetin is a natural flavonol present in edible vegetables, fruits and
wine at 2–160 μg/g concentrations and an ingredient in nutritional
supplements with much higher concentrations. The compound has been
reported to exert anticarcinogenic effects as well as antioxidant and
anti-inflammatory activity via its ability to act as an inhibitor of
cell proliferation and free radical scavenger, respectively. Our
cell-based high-throughput screen for small molecules that override
chemically induced mitotic arrest identified fisetin as an antimitotic
compound. Fisetin rapidly compromised microtubule drug-induced mitotic
block in a proteasome-dependent manner in several human cell lines.
Moreover, in unperturbed human cancer cells fisetin caused premature
initiation of chromosome segregation and exit from mitosis without
normal cytokinesis. To understand the molecular mechanism behind these
mitotic errors, we analyzed the consequences of fisetin treatment on the
localization and phoshorylation of several mitotic proteins. Aurora B,
Bub1, BubR1 and Cenp-F rapidly lost their kinetochore/centromere
localization and others became dephosphorylated upon addition of fisetin
to the culture medium. Finally, we identified Aurora B kinase as a
novel direct target of fisetin. The activity of Aurora B was
significantly reduced by fisetin in vitro and in cells, an
effect that can explain the observed forced mitotic exit, failure of
cytokinesis and decreased cell viability. In conclusion, our data
propose that fisetin perturbs spindle checkpoint signaling, which may
contribute to the antiproliferative effects of the compound.
Original language | English |
---|---|
Pages (from-to) | 1032-1040 |
Journal | Carcinogenesis |
Volume | 30 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2009 |
MoE publication type | A1 Journal article-refereed |
Keywords
- fisetin
- flavonoids
- mitosis
- anticarcinogenic
- antioxidant activity
- antioxidants